General Announcement::NDA for AD Indication of Anti-IL-4Ra Humanized Monoclonal Antibody Injection Accepted in China

Issuer & Securities

Issuer/ Manager
CHINA MEDICAL SYSTEM HOLDINGS LIMITED
Securities
CHINA MEDICAL SYSTEM HLDGS LTD - KYG211081248 - 8A8
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
30-Oct-2025 18:17:04
Status
New
Announcement Sub Title
NDA for AD Indication of Anti-IL-4Ra Humanized Monoclonal Antibody Injection Accepted in China
Announcement Reference
SG251030OTHRNRA3
Submitted By (Co./ Ind. Name)
Wu Sanyan
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)
Please refer to the attachment.

Attachments

CMS-NDA for AD Indication of Long-acting Anti-IL-4Ra Humanized Monoclonal Antibody Injection Accepted in China.pdf
Total size =227K